MAP
Moody Aldrich Partners’s Axsome Therapeutics AXSM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.41M | Sell |
61,410
-929
| -1% | -$97K | 1.24% | 23 |
|
2025
Q1 | $7.27M | Buy |
62,339
+17,201
| +38% | +$2.01M | 1.52% | 16 |
|
2024
Q4 | $3.82M | Sell |
45,138
-15,506
| -26% | -$1.31M | 0.71% | 68 |
|
2024
Q3 | $5.45M | Sell |
60,644
-1,107
| -2% | -$99.5K | 0.99% | 39 |
|
2024
Q2 | $4.97M | Sell |
61,751
-3,908
| -6% | -$315K | 0.97% | 37 |
|
2024
Q1 | $5.24M | Sell |
65,659
-1,207
| -2% | -$96.3K | 0.89% | 41 |
|
2023
Q4 | $5.32M | Sell |
66,866
-6,767
| -9% | -$539K | 0.96% | 40 |
|
2023
Q3 | $5.15M | Buy |
73,633
+8,940
| +14% | +$625K | 0.98% | 37 |
|
2023
Q2 | $4.65M | Buy |
64,693
+32,114
| +99% | +$2.31M | 0.9% | 42 |
|
2023
Q1 | $2.01M | Sell |
32,579
-19,567
| -38% | -$1.21M | 0.41% | 90 |
|
2022
Q4 | $4.02M | Sell |
52,146
-70,115
| -57% | -$5.41M | 0.82% | 55 |
|
2022
Q3 | $5.46M | Buy |
122,261
+79,721
| +187% | +$3.56M | 1.12% | 31 |
|
2022
Q2 | $1.63M | Buy |
+42,540
| New | +$1.63M | 0.32% | 91 |
|
2022
Q1 | – | Sell |
-42,871
| Closed | -$1.62M | – | 154 |
|
2021
Q4 | $1.62M | Sell |
42,871
-8,023
| -16% | -$303K | 0.23% | 103 |
|
2021
Q3 | $1.68M | Buy |
50,894
+6,914
| +16% | +$228K | 0.21% | 101 |
|
2021
Q2 | $2.97M | Sell |
43,980
-585
| -1% | -$39.5K | 0.42% | 85 |
|
2021
Q1 | $2.52M | Buy |
44,565
+952
| +2% | +$53.9K | 0.36% | 87 |
|
2020
Q4 | $3.55M | Sell |
43,613
-75
| -0.2% | -$6.11K | 0.57% | 79 |
|
2020
Q3 | $3.11M | Buy |
43,688
+13,512
| +45% | +$963K | 0.65% | 72 |
|
2020
Q2 | $2.48M | Sell |
30,176
-32,030
| -51% | -$2.64M | 0.53% | 76 |
|
2020
Q1 | $3.66M | Buy |
62,206
+17
| +0% | +$1K | 1.1% | 32 |
|
2019
Q4 | $6.43M | Sell |
62,189
-10,896
| -15% | -$1.13M | 1.32% | 19 |
|
2019
Q3 | $1.48M | Buy |
73,085
+1,510
| +2% | +$30.6K | 0.39% | 84 |
|
2019
Q2 | $1.84M | Buy |
+71,575
| New | +$1.84M | 0.47% | 79 |
|